SCHEMBL3243756

SCHEMBL3243756

Cc1c(C(=O)O)c2cc(=O)ccc-2cn1C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.36
BRD9 Q9H8M2 2/20 0.36
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
AHR P35869 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GFER P55789 1/20 0.34
LDHA P00338 2/20 0.32
LDHB P07195 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
CREBBP Q92793 2/20 0.31
ATM Q13315 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3240963 0.83 LDHA (0.34) BRD4BRD9NPC1MAPTAHR
SCHEMBL3237805 0.81 PTGDR2 (0.39) NPC1MAPTAHRRAB9ASMN1; SMN2
SCHEMBL3633919 0.80 MEN1 (0.45) GFERMEN1KMT2AATMKDM4E
SCHEMBL3237136 0.79 TYR (0.39) BRD4BRD9GFERMEN1KMT2A
SCHEMBL3233960 0.79 NOTUM (0.36) BRD9NPC1MAPTAHRRAB9A
SCHEMBL3631491 0.79 ABCB1 (0.49) SMN1; SMN2LDHALDHBMEN1KMT2A
SCHEMBL3242838 0.78 CASP3 (0.33) GFER
SCHEMBL3239397 0.78 ALDH1A1 (0.40) BRD4RAB9AGFER
SCHEMBL3238452 0.78 BRD9 (0.36) BRD9NPC1RAB9ASMN1; SMN2GFER
SCHEMBL3235748 0.77 GFER (0.35) NPC1MAPTAHRRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028655-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2010-03-18 WO claimed
WO-2010028655-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2010-03-18 WO disclosed